Openbookopenbook
Equity
BLSIF(BLSIF)
USD --+0.00%
Reward45Moderate
Risk47Moderate
📊75%Data
Strong 12994% profit margin · Revenue down 61% YoY
BLSIF
+0.0 · +0.00%
USD · PINK
BLSIF | Healthcare
Earnings Deterioration
Market Cap:9.74M
ℹ️
Reward Rating
45
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
47
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BLSIF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is BLSIF?

engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally.

BLSIF · Verdict

Moderate reward · moderate risk

BLSIF stands out on volatility and balance sheet, but watch the cash flow signal.

Based on 88% data coverage

BLSIF · Verdict

What’s working & what to watch

Strengths 2

  • Volatility75/100

    Above average

  • Balance sheet67/100

    Current ratio 2.72

Watchouts 4

  • Cash flow31/100

    -709% free-cash-flow margin

  • Valuation41/100

    Below average

  • Profitability42/100

    2002% net margin · 68% ROE

  • Growth45/100

    Revenue -63.0% CAGR

Model-based scoring. For information only — not financial advice.

What is BLSIF?

engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 9.74M, and a P/E ratio of 1.5x.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (45)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap9.74M
P/E Ratio1.5
Dividend YieldN/A
52 Week High0.078
52 Week Low0.03
Last AnnualMarch
IPO DateN/A
IncorporatedUSA
Shares Outstanding162M
No. of EmployeesN/A
IndustryBiotechnology
ExchangePINK
Beta-0.072
CurrencyUSD · Reports in CAD
Websitebritannia.life
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.